Home » Topics » BioWorld

BioWorld
RSS

IL-1ra ENTERS CLINICALS FOR CML

June 7, 1991

RSV MAb EFFECTIVE IN ANIMALS

June 7, 1991

BIOCIRCUITS COMPLETES PRIVATE PLACEMENT

June 7, 1991

CAMBRIDGE NEURO, ICOS COMPLETE IPOs

June 7, 1991

INTERFERON SEEKS $10 MILLION IN OFFERING

June 6, 1991

IMMUNOMEDICS FILES FOR OFFERING

June 6, 1991

NEWS BRIEFS

June 6, 1991

BIOTECHNICA GETS FINAL INSTALLMENT

June 6, 1991

FDA STREAMLINES CANCER DRUG REVIEW

June 6, 1991

BCG VACCINE EXPANDS ITS REPERTOIRE

June 6, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...